Asset Comparison and Correlation
|Merck & Co. Inc. vs BristolMyers Squibb Company|
Considering 30-days investment horizon, Merck Co Inc is expected to under-perform the BristolMyers. But the stock apears to be less risky and, when comparing its historical volatility, Merck Co Inc is 1.38 times less risky than BristolMyers. The stock trades about -0.11 of its potential returns per unit of risk. The BristolMyers Squibb Company is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 4,145 in BristolMyers Squibb Company on April 23, 2013 and sell it today you would earn a total of 495.00 from holding BristolMyers Squibb Company or generate 11.94% return on investment over 30 days.
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
Match ups for Merck
89% of all equities and portfolios perform better than BristolMyers Squibb Company. Compared with the overall equity markets, risk-adjusted returns on investments in BristolMyers Squibb Company are ranked lower than 11 (%) of all global equities and portfolios over the last 30 days.
Match ups for BristolMyers